v3.26.1
Restructuring and Related Activities (Tables)
 3 Months Ended
Apr. 05, 2026
Restructuring Cost and Reserve [Line Items]  
Restructuring and Other Costs By Segment [Table Text Block]
Restructuring and other costs, which are included in the selling, general and administrative expenses in the consolidated statements of operations, by segment were as follows:
 
Three Months Ended
April 5,
2026		March 30,
2025
 (In thousands)
Life Sciences$3,229 $2,528 
Diagnostics7,554 135 
Corporate(108)576 
$10,675 $3,239 
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]
The following table summarizes the changes in the Company’s accrued restructuring balance for the first quarter of fiscal year 2026. Other amounts reported as restructuring and other costs during the three months ended April 5, 2026 in the accompanying statement of income have been summarized in the notes to the table. Remaining obligations related to these accounts are expected to be paid over the next 12 months and are included in accrued expenses and other current liabilities in the consolidated balance sheets.
(In thousands)
Balance at December 28, 2025$17,793 
Net restructuring charges incurred in 2026 (a)
7,746 
Payments(11,555)
Balance at April 5, 2026$13,984 
(a) Excludes $2.9 million of charges, principally $1.2 million of lease abandonment charges and $0.4 million of acceleration of depreciation of fixed assets and other charges in the Diagnostics segment and $1.3 million of lease abandonment charges in the Life Sciences segment.